Navigation Links
New book addresses consequences of drought in arid regions
Date:10/28/2013

RIVERSIDE, Calif. Mention of natural disasters usually brings to mind vivid images of shattered concrete and piles of rubbish strewn across the landscape the result of violent hurricanes, massive earthquakes, or rampaging tornadoes. From an economic standpoint, however, the most costly natural disaster in U.S. history ravaged the Midwest in the late eighties with considerably less theatrics. The source of this disaster? Water scarcity. Drought during this period affected crop production, ecosystems, environmental policy, and the lives of scores of Americans.

A new book titled "Drought in Arid and Semi-Arid Regions: A Multidisciplinary and Cross-Country Perspective" (Springer, 2013) provides a multidisciplinary and cross country perspective on ecological, economic, hydrological, agronomical, and policy-related issues arising from water scarcity and drought. Lead editor Kurt Schwabe is an associate professor of environmental economics and policy at the University of California, Riverside and the associate director of the Water Science and Policy Center (WSPC).

"There's a significant amount of meteorological and climate research suggesting that the frequency and intensity of drought is going to increase worldwide," Schwabe said. "We can either wait for a drought, and experiment with costly and lengthy ways to mitigate its effects, or we can learn from the collective successes and failures of countries that have tried to manage it."

"Drought in Arid and Semi-Arid Regions" provides an interdisciplinary guide for addressing and adapting to drought in the future. The idea for the book arose in a 2010 UC Riverside Drought Symposium put on by the WSPC, in which researchers from around the world discussed
'/>"/>

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Prospectus addresses most pressing marine science questions
2. UTHealth study addresses barriers to physical activity counseling
3. Report addresses challenges in implementing new diagnostic tests where they are needed most
4. Healing Method from Australia Addresses the Human Genome
5. Safe levels of environmental pollution may have long-term health consequences
6. A flip of the mitotic spindle has disastrous consequences for epithelial cells
7. College kids who dont drink milk could face serious consequences
8. FASEB SRC announces: Molecular Mechanisms & Physiological Consequences of Protein Aggregation
9. Global warming may have severe consequences for rare Haleakalā silverswords
10. Global warming may have severe consequences for rare Haleakalā silverswords
11. Research reveals contrasting consequences of a warmer Earth
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New book addresses consequences of drought in arid regions
(Date:2/12/2015)... MINNETONKA, Minn. , Feb. 12, 2015 /PRNewswire/ ... technology company specializing in clinical study management systems, ... Partner Program , further distinguishing iMedNet ... for Clinical Research Organizations (CROs) and healthcare consultants.  ... sales support, prospective customer referrals and numerous co-marketing ...
(Date:2/10/2015)... 2015  Alere Inc. (NYSE: ALR), a global ... for the quarter ended December 31, 2014. ... of Alere said, "We made substantial progress in ... global leader in rapid diagnostics and delivering against ... divestiture in early January enabled us to substantially ...
(Date:2/5/2015)... , Feb. 5, 2015  Marken is starting ... company and has launched a new marketing campaign to ... Organization (CLO).  The new campaign focuses on First ... protocol and shipments. The first headline in ... aligns Marken,s priorities with its client,s priorities. Marken recognizes ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35
... known for a long time that some creatures evolve more ... plants. But it may be that height plays a role, ... S. National Evolutionary Synthesis Center. In a study ... Communications , Lanfear and colleagues report that shorter plants have ...
... at USC have found that a class of pharmaceuticals can ... The drugs, known as "TSPO ligands," are currently used for ... of TSPO ligand in young adult mice when pathology was ... was quite severe," said lead researcher Christian Pike of the ...
... Researchers at the University of Illinois at Chicago College of Medicine ... fat -- its main energy source -- and how changes in ... $2 million, 4-year grant from the National Heart, Lung and Blood ... for energy. These changes may play a major role in the ...
Cached Biology News:Small but speedy: Short plants live in the evolutionary fast lane 2Drugs found to both prevent and treat Alzheimer's disease in mice 2Do men's and women's hearts burn fuel differently? 2
(Date:2/27/2015)... 2015  Steep Hill, the industry leader in cannabis ... to open a full service medical cannabis quality assurance ... bringing advanced scientific tools and methodology to the state, ... is currently the only laboratory licensed by the New ... testing in order to meet the recently adopted regulatory ...
(Date:2/26/2015)... , Feb. 26, 2015 On behalf of ... affiliated companies, Wilentz, Goldman & Spitzer, P.A. ... lawsuit against Genewiz Inc. in excess of $10 million. ... GenScript,s trade secrets, and that it improperly hired one ... order denying motions for judgment notwithstanding the verdict, a ...
(Date:2/26/2015)... Feb. 26, 2015   Synageva BioPharma Corp. ... company developing therapeutic products for rare disorders, today ... 2015 goals, other key objectives, and financial guidance.  ... today at 4:30 p.m. EST to review the ... To participate in today,s call by telephone, please ...
(Date:2/26/2015)... , Feb. 26, 2015 DuPont Executive ... priorities driven by key research advancements and product launches ... today,s Bank of America Merrill Lynch 2015 Global Agriculture ... challenge of building grain supplies the last two years, ... at the pace of the last decade, when demand ...
Breaking Biology Technology:Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5
... Leaders ... www.BioConferenceLive.com , ... MA (PRWEB) -- PlatformQ , the leading producer of online events for the healthcare, ... scientific community, today announced that G. Steven Burrill, Chief Executive Officer of Burrill & Company, ...
... , VIENNA, Sept. 30 Intarcia Therapeutics, Inc. today ... of ITCA 650 (DUROS® continuous delivery of exenatide) for ... Conference of the European Association for the Study of ... substantial reductions in fasting plasma glucose (FPG) within 24 ...
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that ... conference call and webcast on Wednesday, October 28, at 5:00 ... , U.S. / Canada Dial-in Number: ... Participant Code: 51404008, Replay Dial-in ...
Cached Biology Technology:CEO of Burrill & Company to Speak at BioConference Live Slated for November 17th and 18th 2CEO of Burrill & Company to Speak at BioConference Live Slated for November 17th and 18th 3Intarcia Therapeutics, Inc. Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabetes Conference 2Intarcia Therapeutics, Inc. Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabetes Conference 3Intarcia Therapeutics, Inc. Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabetes Conference 4Intarcia Therapeutics, Inc. Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabetes Conference 5BioMarin to Host Third Quarter 2009 Financial Results Conference Call and Webcast on Wednesday, October 28 at 5:00 p.m. ET 2
... Lone Wolf valve has the highest performance ... available on the market. This VSO valve ... and ensures maximum accuracy., Achieves rapid, ... and patient comfort. , Maintains ideal flow ...
Normal Hamster Serum...
...
Hamster Serum; U.S. sourced, ideal for those who seek an uncompromising quality. Low Hemoglobin levels; U.S. sourced, ideal for those who seek an uncompromising quality. Low Hemoglobin levels....
Biology Products: